
Katherine Peebles
Examiner (ID: 1636)
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 624 |
| Issued Applications | 201 |
| Pending Applications | 121 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17685680
[patent_doc_number] => 20220192972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Antipsychotic Injectable Depot Composition
[patent_app_type] => utility
[patent_app_number] => 17/672927
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672927 | Antipsychotic injectable depot composition | Feb 15, 2022 | Issued |
Array
(
[id] => 18969628
[patent_doc_number] => 20240049720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => A SYNERGISTIC AGRICULTURAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/546522
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546522 | A SYNERGISTIC AGRICULTURAL COMPOSITION | Feb 15, 2022 | Pending |
Array
(
[id] => 17733209
[patent_doc_number] => 20220218668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/669595
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669595 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION | Feb 10, 2022 | Abandoned |
Array
(
[id] => 19081783
[patent_doc_number] => 20240108584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => POLYMERIC MICROPARTICLES, COMPOSITIONS, AND METHODS FOR SUSTAINED RELEASE OF AN ACTIVE AGENT SUSCEPTIBLE TO ABUSE
[patent_app_type] => utility
[patent_app_number] => 18/274964
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274964
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274964 | POLYMERIC MICROPARTICLES, COMPOSITIONS, AND METHODS FOR SUSTAINED RELEASE OF AN ACTIVE AGENT SUSCEPTIBLE TO ABUSE | Jan 30, 2022 | Pending |
Array
(
[id] => 19081884
[patent_doc_number] => 20240108685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ORAL LIPOSOMAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/263248
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263248 | ORAL LIPOSOMAL COMPOSITIONS | Jan 27, 2022 | Pending |
Array
(
[id] => 17593372
[patent_doc_number] => 20220142945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => FORMULATIONS INCLUDING DIHYDROHONOKIOL
[patent_app_type] => utility
[patent_app_number] => 17/584553
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584553 | FORMULATIONS INCLUDING DIHYDROHONOKIOL | Jan 25, 2022 | Abandoned |
Array
(
[id] => 19599390
[patent_doc_number] => 20240390270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE
[patent_app_type] => utility
[patent_app_number] => 18/272786
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272786 | GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE | Jan 18, 2022 | Pending |
Array
(
[id] => 18634845
[patent_doc_number] => 11759416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Antipsychotic injectable depot composition
[patent_app_type] => utility
[patent_app_number] => 17/577170
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 36
[patent_no_of_words] => 25833
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577170 | Antipsychotic injectable depot composition | Jan 16, 2022 | Issued |
Array
(
[id] => 19111155
[patent_doc_number] => 20240122905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/267637
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267637
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267637 | PHARMACEUTICAL COMPOSITION | Dec 14, 2021 | Pending |
Array
(
[id] => 17546810
[patent_doc_number] => 20220118151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => FOAM IN WOUND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/544987
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544987 | FOAM IN WOUND TREATMENT | Dec 7, 2021 | Pending |
Array
(
[id] => 17576918
[patent_doc_number] => 20220133773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => MEDICAMENT CONTAINING MODIFIED STARCH FOR THE TREATMENT OF ANASTOMOSES
[patent_app_type] => utility
[patent_app_number] => 17/527928
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527928 | MEDICAMENT CONTAINING MODIFIED STARCH FOR THE TREATMENT OF ANASTOMOSES | Nov 15, 2021 | Abandoned |
Array
(
[id] => 18970376
[patent_doc_number] => 20240050468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => FORMULATION COMPRISING ERBIUM BORATE FOR USE IN PREVENTION AND TREATMENT OF WOUND SCARS
[patent_app_type] => utility
[patent_app_number] => 18/268997
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268997 | FORMULATION COMPRISING ERBIUM BORATE FOR USE IN PREVENTION AND TREATMENT OF WOUND SCARS | Nov 8, 2021 | Pending |
Array
(
[id] => 18829719
[patent_doc_number] => 20230398243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/035174
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035174 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | Nov 2, 2021 | Pending |
Array
(
[id] => 17412601
[patent_doc_number] => 20220047505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration
[patent_app_type] => utility
[patent_app_number] => 17/515022
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515022 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | Oct 28, 2021 | Pending |
Array
(
[id] => 18815858
[patent_doc_number] => 20230390197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/250065
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250065
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250065 | MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY | Oct 25, 2021 | Pending |
Array
(
[id] => 19947140
[patent_doc_number] => 12318478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Risperidone or paliperidone implant formulation
[patent_app_type] => utility
[patent_app_number] => 17/498514
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 15102
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498514 | Risperidone or paliperidone implant formulation | Oct 10, 2021 | Issued |
Array
(
[id] => 18842741
[patent_doc_number] => 20230405145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 18/248139
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248139 | IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA | Oct 5, 2021 | Pending |
Array
(
[id] => 17355217
[patent_doc_number] => 20220016013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITION COMPRISING AN ALKOXYSILANE, A FATTY ESTER AND A SILICONE, AND COSMETIC USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/491787
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491787 | COMPOSITION COMPRISING AN ALKOXYSILANE, A FATTY ESTER AND A SILICONE, AND COSMETIC USE THEREOF | Sep 30, 2021 | Pending |
Array
(
[id] => 18859378
[patent_doc_number] => 20230413811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TRIALKYL SULFONIUM CHLORIDES AS FUNGICIDES
[patent_app_type] => utility
[patent_app_number] => 18/029782
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029782 | TRIALKYL SULFONIUM CHLORIDES AS FUNGICIDES | Sep 30, 2021 | Pending |
Array
(
[id] => 18921227
[patent_doc_number] => 20240024231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Hydrogel material
[patent_app_type] => utility
[patent_app_number] => 18/029927
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029927
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029927 | Hydrogel material | Sep 28, 2021 | Pending |